{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:49Z","timestamp":1790796229151,"version":"4.1.0"},"reference-count":25,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,12,16]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>We report the case of a 43-year-old man, suffering from ankylosing spondylitis and treated with Infliximab 5\u2009mg\/kg every 2 months, with an excellent disease control. During a follow-up consultation, an incipient renal insufficiency is detected. A urine analysis showed haematuria and proteinuria and a renal puncture-biopsy revealed an image of IgA nephropathy.<\/jats:p>\n               <jats:p>Several cases of IgA nephropathy have been reported in the literature associated with ankylosing spondylitis. Some of them occur in patients treated with antitumour necrosis factor, but it is unclear whether this pathology is caused by the treatment or whether treatment failed to prevent its occurrence.<\/jats:p>\n               <jats:p>Our clinical case highlights the importance of regular monitoring of renal function in patients with ankylosing spondylitis, as well as urinary spotting.<\/jats:p>\n               <jats:p>The question of whether the disease itself, the treatment or other factors such as immune dysregulation could be held responsible for kidney disease will be addressed in the discussion.<\/jats:p>","DOI":"10.1136\/bcr-2020-237713","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:16:18Z","timestamp":1611918978000},"page":"e237713","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis"],"prefix":"10.1136","volume":"14","author":[{"given":"Charlotte Anne","family":"Baert","sequence":"first","affiliation":[{"name":"Rheumatology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Aydin","sequence":"additional","affiliation":[{"name":"Rheumatology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Leroy","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHR Mons-Hainaut, Mons, Hainaut, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-2356","authenticated-orcid":false,"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[{"name":"Rheumatology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"2025082723260092000_14.1.e237713.1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318294457f"},{"key":"2025082723260092000_14.1.e237713.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01451293"},{"key":"2025082723260092000_14.1.e237713.3","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","article-title":"Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-A blocker","volume":"33","author":"Lee","year":"2013","journal-title":"Rheumatol Int"},{"key":"2025082723260092000_14.1.e237713.4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/acr.22176","article-title":"Estimating the occurrence of renal complications among persons with ankylosing spondylitis","volume":"66","author":"Levy","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2025082723260092000_14.1.e237713.5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/03009749709065659","article-title":"Renal abnormalities in ankylosing spondylitis","volume":"26","author":"Vilar","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"2025082723260092000_14.1.e237713.6","first-page":"169","article-title":"Glomerulonephritis in ankylosing spondylitis","volume":"25","author":"Shu","year":"1986","journal-title":"Clin Nephrol"},{"key":"2025082723260092000_14.1.e237713.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/26.5.341"},{"key":"2025082723260092000_14.1.e237713.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.3.174"},{"key":"2025082723260092000_14.1.e237713.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070265"},{"key":"2025082723260092000_14.1.e237713.10","doi-asserted-by":"publisher","DOI":"10.1159\/000343398"},{"key":"2025082723260092000_14.1.e237713.11","doi-asserted-by":"crossref","unstructured":"Karras A , Champtiaux N , Thevert E , et al . Atteintes r\u00e9nales dans les spondyloarthrites. Revue du rhumatisme monographies 2014;82.doi:10.1016\/j.monrhu.2014.06.001","DOI":"10.1016\/j.monrhu.2014.06.001"},{"key":"2025082723260092000_14.1.e237713.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5984.611"},{"key":"2025082723260092000_14.1.e237713.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020109"},{"key":"2025082723260092000_14.1.e237713.14","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199907000-00007"},{"key":"2025082723260092000_14.1.e237713.15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp314"},{"key":"2025082723260092000_14.1.e237713.16","article-title":"Iga nephropathy in an ankylosing spondylitis patient during infliximab therapy: chicken, egg or mother and child reunion?","volume":"38","author":"Oz\u00e7akar","year":"2013","journal-title":"Acta Reumatol Port"},{"key":"2025082723260092000_14.1.e237713.17","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0b013e3181aaeb33","article-title":"Amyloidosis in ankylosing spondylitis","volume":"15","author":"Agarwal","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"2025082723260092000_14.1.e237713.18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg010"},{"key":"2025082723260092000_14.1.e237713.19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2002.00193.x","article-title":"Polymorphism of the cytokine genes and IgA nephropathy","volume":"61","author":"Syrj\u00e4nen","year":"2002","journal-title":"Kidney Int"},{"key":"2025082723260092000_14.1.e237713.20","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.153.11.5247","article-title":"Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation","volume":"153","author":"G\u00f3mez-Guerrero","year":"1994","journal-title":"J Immunol"},{"key":"2025082723260092000_14.1.e237713.21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm581"},{"key":"2025082723260092000_14.1.e237713.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67116.x"},{"key":"2025082723260092000_14.1.e237713.23","article-title":"Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis","volume":"28","author":"Marocchi","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2025082723260092000_14.1.e237713.24","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D"},{"key":"2025082723260092000_14.1.e237713.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0422-z"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-237713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:26:11Z","timestamp":1756362371000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-237713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-237713"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-237713","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}